https://doi.org/10.4081/itjm.2025.2052
A case of acute psychotic episode at the onset of primary aldosteronism
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 8 September 2025
Primary aldosteronism (PA) is a common cause of secondary hypertension. Moreover, the spectrum of clinical manifestations of PA may involve a more extensive continuum and different clinical manifestations, including also neuropsychiatric symptoms. Until now, there have been only a few reports of psychiatric symptoms in patients with PA. Here, we describe a case of PA presenting with an acute psychotic episode. A 55-year-old Asian woman with no pathological history was admitted to the emergency room because of altered mental status with confusion and agitation, recurrent speech, and unmotivated laughter lasting for approximately 36 hours. The clinical manifestation was initially considered psychiatric and treated with olanzapine and lorazepam. She presented as hypertensive. The laboratory showed hypokalemia. PA was suspected and then confirmed by a saline infusion and captopril test. An abdominal computed tomography scan showed a left adrenal cortical adenoma. Significant left lateralization at adrenal vein sampling was obtained. We suggest considering PA in the differential diagnosis of hypertensive patients with psychiatric manifestations.
Downloads
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889-916. DOI: https://doi.org/10.1210/jc.2015-4061
Reincke M. Anxiety, depression, and impaired quality of life in primary aldosteronism: Why we shouldn’t ignore it! J Clin Endocrinol Metab 2018;103:1-4. DOI: https://doi.org/10.1210/jc.2017-02141
Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev 2018;39:1057-88. DOI: https://doi.org/10.1210/er.2018-00139
Huang WC, Liu FH, Cheng HM, et al. Who needs to be screened for primary aldosteronism? J Formos Med Assoc 2024;123:S82-90. DOI: https://doi.org/10.1016/j.jfma.2023.08.021
Künzel HE. Psychopathological symptoms in patients with primary hyperaldosteronism - possible pathways. Horm Metab Res 2012;44:202-7. DOI: https://doi.org/10.1055/s-0032-1301921
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.